jump to example.com
newsletter linked in

UVa. makes breakthrough in peripheral arterial disease

uva-logoA discovery at the University of Virginia School of Medicine is opening up new avenues for treating peripheral arterial disease (PAD), a common circulation problem that afflicts millions of Americans. Researchers have pinpointed a key genetic regulator that appears to controls the ability to adapt to blockages in blood vessels – and it turns out to be a tiny RNA molecule.

The finding gives researchers a new target for potential therapies to treat patients with peripheral arterial disease, as well as allowing them to better understand the progression of the disease in patients.

“Why does one person with peripheral arterial disease remain stable and do well while another person has a much worse clinical course? We need to begin to unravel these types of questions,” said Brian Annex, MD, division chief of cardiovascular medicine at UVA. “When we see a patient with peripheral arterial disease, the reality is that information we get out of their age, gender, risk factors and basic clinical measures doesn’t tell us how the patient is going to do. We’re often left with uncertainty. I think as we begin to understand the [implications of the discovery] we will better understand PAD and open up entirely new treatment approaches.”

The Causes of PAD
Peripheral arterial disease is caused by atherosclerosis that builds up inside the arteries and impedes blood flow, most often to the legs. Treatments to date have been ineffective at improving blood flow in PAD.

UVA’s discovery may help change that. The researchers determined that a specific “microRNA” molecule, microRNA-93, appears to control the expression of several related genes in mouse models of PAD.

“This microRNA had profound effects on both endothelial and muscle cells. Whether we used a gain of function or loss of function, in pretty much every situation, whenever we got a gain of function or a therapeutic benefit, the microRNA was present at a higher level and suppressed three genes,” Annex said. “Whenever you had less miR-93, you had more expression of these and a poorer response to injury/repair.”

Overturning Orthodoxy
Scientists once thought that microRNAs were effectively junk with no ability to generate proteins. But recently microRNAs have emerged as major regulators of how genes respond to injury. In the case of PAD, the UVA researchers found, microRNA-93 directs how genes react to the restriction in blood supply.

“The central dogma of molecular biology — that DNA makes RNA and RNA makes protein — is probably wrong more often than it’s right,” Annex said.

New Treatments for Peripheral Arterial Disease
UVA’s discovery presents an exciting new possibility of treating PAD by boosting the effects of microRNA-93, Annex said.

“To date, drugs used to treat patients with PAD have always tried to target a single gene, whereas it’s very clear this microRNA has significant effects on multiple related genes,” Annex said. “This opens up an entirely new paradigm for treating and understanding peripheral arterial disease.”

While more research needs to be done, Annex foresees several potential ways doctors could manipulate microRNA-93 to target PAD and avoid problems that plague other efforts to develop new treatments.

“One can imagine a direct strategy of delivering the microRNA, one can imagine a strategy to change the body’s own expression of the microRNA, one can try to figure out ways to prevent the breakdown of the microRNA,” he said. “Many of the strategies that are being set up to treat patients with peripheral arterial disease try to grow new blood vessels. Our microRNA will grow blood vessels, but what’s absolutely fascinating is that … it not only makes new blood vessels, but the blood vessels have structure and architecture and may very well get around the prior problems where drugs cause the development of leaky, malformed blood vessels.”

Published in 
Circulation
The new findings have been detailed in a paper published online by the journal Circulation. The article was authored by Surovi Hazarika, MD, PhD; Charles R. Farber, PhD; Ayotunde O. Dokun, MD, PhD; Achilleas N. Pitsillides, PhD; Tao Wang, MD, PhD; R. John Lye, PhD; and Annex.

Discussion
 
Top Stories
a

Fishburne Military School welcomes 12th superintendent

Fishburne Military School has officially selected retired Navy Captain Mark E. Black as the school’s 12th superintendent.

How to cut through the SEO, marketing BS

I recently met a nice young man who went full sales pitch on me within five seconds of shaking my hand about how he could help improve my SEO.

The first Alzheimer’s survivor: Advocates have goal in mind

An Alzheimer’s diagnosis seems to come with finality. But advocates are looking to the day when we can say we’ve had our first Alzheimer’s survivor.

New Valley Real Estate Brokers website designed by Augusta Free Press

Valley Real Estate Brokers, based in Waynesboro and Staunton, has a new website designed by Augusta Free Press.

Suicide prevention walk to be held at Gypsy Hill Park

For the second year, suicide prevention advocates and survivors will walk together to bring the topic of suicide out of the darkness.

Roanoke College poll: Hillary Clinton with big lead in Virginia

Democratic presidential candidate Hillary Clinton has a yu-u-uge lead on Republican Donald Trump in Virginia, according to a new Roanoke College poll released on Tuesday.

 
Recent News

Viewpoints
 
Hosts Chris Graham and Crystal Graham of Augusta Free Press highlight local news and newsmakers with an emphasis on the Shenandoah Valley on Viewpoints on WVPT.

Join the conversation on WVPT's Facebook page.

Chris Graham is the editor of Augusta Free Press, ESPN3 baseball broadcaster and the author of five books. Crystal Graham is the award-winning former host of WVPT’s Virginia Tonight.

Show airs Wednesday nights at 7:30 p.m.

Want to see what's coming up on Viewpoints? Click here.

Missed a show? Watch OnDemand and on our YouTube channel.

Past shows are also available via the PBS app wherever it is available (iOS, Xbox, Roku, Android, etc). Videos will be found more easily if you localize the app and select WVPT as your local PBS station.

AFP Business

Your One-Stop Media Shop

Augusta Free Press LLC provides clients in the Shenandoah Valley and Central Virginia and beyond with marketing and PR solutions including web design, magazine/brochure, TV/radio, social media and overall marketing campaign design and implementation.
 

Advertise

Get information on readership and advertising online with us.


AFP Classes

Augusta Free Press offers a series of hour-long classes on website design, marketing strategy, social media, event planning and more.


Web Design

You want a new website, but don’t have the first clue as to how to build one. That’s our job. Get your business online for as little as $1,299.


Graphic Design

Whether you need a fresh business card design, rack card, ad, flyer or full magazine design, we can help with all your graphic-design needs.


Marketing/PR

Augusta Free Press manages advertising campaigns for small- and medium-sized businesses across Virginia. You don’t need to hire a full-time marketing coordinator. Bring the experience of the Augusta Free Press team to work for you – for a fraction of the cost.


Search Engine Optimization

The prettiest website in the world is like a tree falling in the forest with no one there to hear it. If your website hasn’t been search engine optimized, no one is going to see it or hear it – and it’s not going to work for you.


Video/Audio

Web videos, TV and radio commercials, DVDs – Augusta Free Press LLC has you covered when it comes to video and audio production.